ClinicalTrials.gg
Status unknownNCT02890238Updated Sep 23, 2019

Sildenafil Effect After Ovulation Induction

A Phase 4 interventional study of Clomiphene citrate and sildenafil citrate in Infertility, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2019-09-23.

Sponsored by Cairo University · Phase 4, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 52 studies in Infertility by Cairo University — none open to participants now, none under way, none of them phase 3. Infertility · Cairo University.

Planned enrollment
32nd of 43
100 · median 160
Started
2016
with 3 others
Phase 4
8 of 52
none open now
Registered
37th of 52
by date

Among the 52 studies in Infertility by Cairo University, this one is the 32nd largest by planned enrollment of the 43 interventional ones that give a count, is one of 4 that started in 2016, is one of 8 in phase 4, and was the 37th registered.

Infertility

2,090 studies on the registry are indexed under Infertility; 355 are open to participants now.

Browse Infertility studies →

Open to participants now

None of the 52 studies in Infertility by Cairo University is open now. The open studies under Infertility, anywhere →

Where they have run

Who these studies take

Of the 232 Infertility studies recruiting now, 43 (19%) set no upper age limit and 183 (79%) stop at 75 or younger; 27 take children under 18; 74 take healthy volunteers.

This study: 18 Years to 35 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 52 studies in Infertility by Cairo University as a file.
02

Study summary

100 women with infertility classified into 2 groups.

Group A: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and sildeaynafil citrate 20mg tab from 7th-11th day of the same cycle orally 3 times/day.

Group B: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and placebo tablets from 7th-11th day of the same cycle orally 3 times/day.

Read the detailed description

100 women with infertility classified into 2 groups.

Group A: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and sildeaynafil citrate 20mg tab from 7th-11th day of the same cycle orally 3 times/day.

Group B: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and placebo tablets from 7th-11th day of the same cycle orally 3 times/day.

Folliculometry was assessed by:

  • Transvaginal ultrasound: It was done on day 11th of the cycle to detect number of follicles and endometrial thickness.

When the follicles reach ≥18 ml, injection of 5000 IU of HCG IM to trigger ovulation to both groups.

Pregnancy was assessed by:

  • Beta HCG test: (Radioimmunoassay)
03

Conditions studied

  • Infertility

Browse trials for

Keywords

  • Sildenafil Citrate
  • Induction of Ovulation
  • Pregnancy Rate
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Infertile women whether it's primary or secondary infertility
  2. Woman's age: (18-35 years old)
  3. Menstrual cycle from (24-35 days)
  4. Normal semen analysis

Exclusion criteria

Exclusion Criteria:

  1. Age more than 35 years old
  2. Ovarian cysts
  3. Abnormal hormonal profile (e.g hyperprolactinaemia)
  4. Significant cardiovascular disease
  5. Serious liver disease or renal failure
  6. Poorly controlled diabetes mellitus
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    sildenafil citrate

    50 women who will be given clomiphene citrate 50mg (clomid,) orally 2times/day from 2rd - 7th day of the cycle and sildenafil citrate 20mg tab from 7th-11th day of the same cycle orally 3times/day

    Drug: Clomiphene citrate · Drug: sildenafil citrate

  • Placebo comparator
    placebo group

    50 women who will be given clomiphene citrate 50mg (clomid,) orally 2times/day from 2rd- 7th day of the cycle and placebo tablets from 7th-11th day of the same cycle orally 3 times/day

    Drug: Clomiphene citrate · Drug: Placebo

Interventions

  • DrugClomipheneStudies of ClomipheneClomiphene pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    50mg (clomid,) orally 2 times/day from 2nd- 7th day of the cycle

    Also known as: clomid

  • DrugSildenafilStudies of SildenafilSildenafil pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    20mg tab from 7th-11th day of the same cycle orally 3times/day

    Also known as: Viagra

  • DrugPlacebo

    tab from 7th-11th day of the same cycle orally 3times/day

06

What researchers measure

Primary outcomes

  1. Pregnancy rate per cycle

    Serum pregnancy test

    Time frame: 14 days after HCG triggering of ovulation

07

Study locations

1 of 1 sites recruiting
  • Kasr Alainy medical school
    Cairo, 12151, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2016, a primary completion of Oct 2019 and a completion of Dec 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2016
First posted
Sep 7, 2016
Start
Aug 2016
Primary completionEst.
Oct 2019
CompletionEst.
Dec 2019
Last update
Sep 23, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02890238
Lead sponsor
Cairo University
Responsible party
Ahmed M Maged, MD (Assistant professor, Cairo University) — Principal investigator
First posted
Sep 7, 2016
Start date
Aug 2016
Primary completion
Oct 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Sep 23, 2019

Study contacts

Ahmed Maged
Contact
prof.ahmedmaged@gmail.com
01005227404
Ahmed Maged
principal investigator · Kasr Alainy medical school

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Sildenafil

Start the discussion